Fangdie Ye

560 total citations
34 papers, 395 citations indexed

About

Fangdie Ye is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Fangdie Ye has authored 34 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 19 papers in Pulmonary and Respiratory Medicine and 14 papers in Cancer Research. Recurrent topics in Fangdie Ye's work include Ferroptosis and cancer prognosis (17 papers), Bladder and Urothelial Cancer Treatments (11 papers) and Epigenetics and DNA Methylation (9 papers). Fangdie Ye is often cited by papers focused on Ferroptosis and cancer prognosis (17 papers), Bladder and Urothelial Cancer Treatments (11 papers) and Epigenetics and DNA Methylation (9 papers). Fangdie Ye collaborates with scholars based in China, Germany and United States. Fangdie Ye's co-authors include Yufei Liu, Haowen Jiang, Chen Yang, Yingchun Liang, Yuxi Ou, Haowen Jiang, Quan Zhou, Yun Hu, Jiahao Gao and Chenyang Xu and has published in prestigious journals such as Journal of Colloid and Interface Science, Frontiers in Immunology and Cancer Letters.

In The Last Decade

Fangdie Ye

34 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangdie Ye China 13 223 154 151 93 61 34 395
Ziling Huang China 11 171 0.8× 98 0.6× 171 1.1× 86 0.9× 26 0.4× 27 401
Daping Yu China 11 215 1.0× 190 1.2× 155 1.0× 93 1.0× 36 0.6× 34 476
Radosław Charkiewicz Poland 13 197 0.9× 132 0.9× 72 0.5× 73 0.8× 106 1.7× 36 473
Weiying Li China 11 143 0.6× 106 0.7× 97 0.6× 126 1.4× 37 0.6× 29 363
Jiumin Liu China 9 203 0.9× 160 1.0× 124 0.8× 57 0.6× 45 0.7× 32 362
Xianli He China 10 242 1.1× 143 0.9× 96 0.6× 142 1.5× 37 0.6× 19 469
Jingsi Dong China 12 147 0.7× 153 1.0× 210 1.4× 184 2.0× 30 0.5× 29 501
Changshun Yang China 9 174 0.8× 122 0.8× 166 1.1× 105 1.1× 22 0.4× 33 364
Jingtai Zhi China 13 231 1.0× 77 0.5× 68 0.5× 102 1.1× 31 0.5× 29 443
Yunfeng Li China 8 209 0.9× 139 0.9× 74 0.5× 199 2.1× 87 1.4× 15 416

Countries citing papers authored by Fangdie Ye

Since Specialization
Citations

This map shows the geographic impact of Fangdie Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangdie Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangdie Ye more than expected).

Fields of papers citing papers by Fangdie Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangdie Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangdie Ye. The network helps show where Fangdie Ye may publish in the future.

Co-authorship network of co-authors of Fangdie Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Fangdie Ye. A scholar is included among the top collaborators of Fangdie Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangdie Ye. Fangdie Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Quan, Zongyan, et al.. (2025). Bioinspired glycocalyx-mimetic hydrogel enabling photothermal-amplified therapeutic cascade for chronic wound healing. Journal of Colloid and Interface Science. 694. 137669–137669. 1 indexed citations
2.
Wang, Jie, et al.. (2025). The Potential Role of Zika and Dengue Virus Infection in the Urogenital System Disorders: An Overview. Reviews in Medical Virology. 35(1). e70010–e70010. 2 indexed citations
3.
Jiang, Haoran, Yuan Zeng, Li P, et al.. (2025). Ketogenesis instigates immune suppression in enzalutamide resistant prostate cancer via OTUD7B β-hydroxybutyrylation. Cancer Letters. 625. 217808–217808. 2 indexed citations
4.
Yang, Qiwei, Fangdie Ye, Lin Li, et al.. (2024). Integration analysis of PLAUR as a sunitinib resistance and macrophage related biomarker in ccRCC, an in silicon and experimental study. Journal of Biomolecular Structure and Dynamics. 43(8). 3956–3973. 1 indexed citations
5.
Li, Weijian, et al.. (2024). cirSIRT5 induces ferroptosis in bladder cancer by forming a ternary complex with SYVN1/PHGDH. Cell Death Discovery. 10(1). 391–391. 5 indexed citations
6.
Zhang, Tianxiang, Weijian Li, Jia Hu, et al.. (2024). Single-cell RNA sequencing analysis reveals the dynamic changes in the tumor microenvironment during NMIBC recurrence. APOPTOSIS. 30(1-2). 282–296. 1 indexed citations
7.
Ou, Yuxi, et al.. (2024). Machine learning identifies the role of SMAD6 in the prognosis and drug susceptibility in bladder cancer. Journal of Cancer Research and Clinical Oncology. 150(5). 264–264. 8 indexed citations
8.
Huang, He, Qian Li, Kongyuan Wei, et al.. (2024). DNA hypomethylation patterns and their impact on the tumor microenvironment in colorectal cancer. Cellular Oncology. 47(4). 1375–1389. 5 indexed citations
9.
Ye, Fangdie, Yingchun Liang, Chenyang Xu, et al.. (2023). Blood lipids, lipid-regulatory medications, and risk of bladder cancer: a Mendelian randomization study. Frontiers in Nutrition. 10. 992608–992608. 4 indexed citations
10.
Li, Weijian, Chen Yang, Fangdie Ye, et al.. (2023). Identification of a novel ferroptosis-inducing micropeptide in bladder cancer. Cancer Letters. 582. 216515–216515. 18 indexed citations
12.
Wang, Jie, et al.. (2023). Single-cell transcriptome analysis revealing the intratumoral heterogeneity of ccRCC and validation of MT2A in pathogenesis. Functional & Integrative Genomics. 23(4). 300–300. 20 indexed citations
13.
Liu, Yufei, et al.. (2023). Use of in vivo Raman spectroscopy and cryoablation for diagnosis and treatment of bladder cancer. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 308. 123707–123707. 4 indexed citations
14.
Ye, Fangdie, Yingchun Liang, Yufei Liu, et al.. (2022). Immunological Characteristics of Alternative Splicing Profiles Related to Prognosis in Bladder Cancer. Frontiers in Immunology. 13. 911902–911902. 12 indexed citations
15.
Gao, Jiahao, Fangdie Ye, Fang Han, Haowen Jiang, & Jiawen Zhang. (2022). A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma. Frontiers in Immunology. 13. 956679–956679. 19 indexed citations
16.
Ye, Fangdie, Min Xiong, Bingqiu Xiu, et al.. (2022). Cross-talk of four types of RNA modification proteins with adenosine reveals the landscape of multivariate prognostic patterns in breast cancer. Frontiers in Genetics. 13. 943378–943378. 3 indexed citations
17.
Gao, Jiahao, Fangdie Ye, Fang Han, et al.. (2021). A Novel Radiogenomics Biomarker Based on Hypoxic-Gene Subset: Accurate Survival and Prognostic Prediction of Renal Clear Cell Carcinoma. Frontiers in Oncology. 11. 739815–739815. 10 indexed citations
18.
Liang, Yingchun, Fangdie Ye, Cheng Zhang, et al.. (2021). Calculated identification of mutator-derived lncRNA signatures of genomic instability to predict the clinical outcome of muscle-invasive bladder cancer. Cancer Cell International. 21(1). 476–476. 2 indexed citations
19.
Ye, Fangdie, Yun Hu, Jiahao Gao, et al.. (2021). Radiogenomics Map Reveals the Landscape of m6A Methylation Modification Pattern in Bladder Cancer. Frontiers in Immunology. 12. 722642–722642. 31 indexed citations
20.
Ye, Fangdie, Yingchun Liang, Yun Hu, et al.. (2021). DNA Methylation Modification Map to Predict Tumor Molecular Subtypes and Efficacy of Immunotherapy in Bladder Cancer. Frontiers in Cell and Developmental Biology. 9. 760369–760369. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026